FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Apotex Timolol Maleate Ophthalmic Solution Recall

Timolol Maleate Ophthalmic Solution, USP 0

Apotex Corp. · Weston, FL

Risk level
Class III
Reported by FDA
Jan 4, 2023
Recall ID
D-0093-2023
Check your lot numberHow we source this data

Summary

Apotex recalled Timolol Maleate Ophthalmic Solution starting Dec 21, 2022. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0093-2023 on Jan 4, 2023. Reason: Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life. Status: Terminated.

Why it was recalled

Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.

Product description

Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp. Weston, FL 33326, NDC 60505-1005-4

Lot numbers, UPCs & expiration codes

Lot# TA4844, Exp 03/2023

Where it was sold

USA Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0093-2023
Classification
Class III
Status
Terminated
Recall initiated
Dec 21, 2022
FDA report date
Jan 4, 2023
Quantity
22,027 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Corp.

Original FDA data

Every field from FDA enforcement report D-0093-2023, exactly as published.

Show all FDA fields
City
Weston
State
FL
Status
Terminated
Country
United States
Event ID
91353
Address
2400 N Commerce Pkwy Ste 400
Code information
Lot# TA4844, Exp 03/2023
Postal code
33326-3253
Report date
Jan 4, 2023
Product type
Drugs
Recall number
D-0093-2023
Classification
Class III
Recalling firm
Apotex Corp.
Product quantity
22,027 bottles
Termination date
Oct 8, 2025
Reason for recall
Failed Stability Specifications: Out of specification for weight loss at the 18-month stability timepoint and projected weight loss of 21.1% at shelf life.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Timolol Maleate Ophthalmic Solution, USP 0.5%, 2.5 mL, Rx Only, Mfg by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Mfg for: Apotex Corp. Weston, FL 33326, NDC 60505-1005-4
Distribution pattern
USA Nationwide
Recall initiation date
Dec 21, 2022
Initial firm notification
Letter
Center classification date
Dec 28, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0093-2023, published Jan 4, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls